Logo Ventures

Logo Ventures is the corporate VC arm of Logo Software, one of Turkey’s largest ERP and business software companies, with a strategic focus on B2B SaaS and enterprise technology including healthcare software. Stage focus is seed and Series A with checks in the $250k to $1M range, and AI is a stated focus. The strategic logic flows directly from Logo Software’s core business: investments are made to integrate emerging enterprise technologies with Logo’s existing customer base, which spans tens of thousands of Turkish SMEs and mid-market companies. The right founder is a Turkish or CEE technical operator building B2B healthcare software, healthcare ERP add-ons, AI-enabled clinical or administrative workflow tools, or healthcare data platforms with credible Turkish-market wedge and either CEE or MENA expansion logic. The wrong founder is a consumer health brand, a regulated medtech or therapeutics team, or a US-pedigreed founder without a Turkish-market thesis. Intro paths run through Logo Software’s executive team and its broader Istanbul B2B technology network, frequent co-investors and follow-on partners including 212, Earlybird Digital East, Maxis VC, and Revo Capital, and through Endeavor Turkey and the broader CEE venture community. Direct outreach is acknowledged but warm intros from Logo Software’s executive bench or existing portfolio CEOs accelerate the process meaningfully. In the pitch, lead with the strategic angle: how does your healthcare software create incremental value for a major ERP customer base, including potential go-to-market leverage through Logo’s channel, billing integration, or data interoperability. Show real customer evidence including one or two anchor Turkish health system or pharma customers, the unit economics in Turkish Lira with realistic FX assumptions, and a clear-eyed view of KVKK compliance and Ministry of Health Turkey posture. Be specific about your AI architecture and what is genuinely defensible about your data moat. Caveats are the standard CVC ones, including the inherent tensions of corporate venture and the reality that Logo’s strategic priorities can shift between fund vintages. Turkish FX volatility adds an additional layer of planning complexity. For Turkish or CEE B2B healthcare software founders with a credible enterprise wedge, Logo Ventures is a genuinely useful strategic partner; for founders outside that profile, it is a forced fit.